STOCK TITAN
  1. Home
  2. News
  3. MOTS

Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Motus GI Holdings, Inc. to present at H.C. Wainwright 25th Annual Global Investment Conference
Positive
  • None.
Negative
  • None.

FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that Mark Pomeranz, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference.

H.C. Wainwright 25th Annual Global Investment Conference
Presentation Date:Monday, September 11, 2023 at 7:00 AM ET
Meetings:Management is participating in virtual investor meetings on September 11 – 14, 2023
Webcast:https://journey.ct.events/view/d901ec90-604f-458e-8973-a36787a54f8e
  

A replay of the webcast will be archived on the Events page on the company’s website, www.motusgi.com and will be available for 90 days.

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.

Investor Contact:

Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com


Stock MOTS logo
MOTUS GI HOLDINGS INC

OTC:MOTS

MOTS Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

MOTS Latest News

Mar 18, 2024
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Feb 29, 2024
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
Feb 22, 2024
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
Feb 21, 2024
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
Feb 16, 2024
Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

MOTS Stock Data

435.11k
4.97M
1.12%
4.71%
0.45%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
FT. LAUDERDALE

About MOTS

motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.